ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Artificial Intelligence
      • Beyond Basic Beta
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Education
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Managed Futures
      • Market Insights
      • Modern Alpha
      • Responsible Investing
      • Retirement Income
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Commodities
        • Gold/Silver/Critical Minerals
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook Channel
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Modern Alpha Channel
  2. The Powerful WDNA Promise of Genetics Research
Modern Alpha Channel
Share

The Powerful WDNA Promise of Genetics Research

Tom LydonDec 17, 2021
2021-12-17

Genomics represents one of the most disruptive, opportunity-rich investment frontiers, but stock picking in this space is tricky, to say the least.

That underscores the utility of various genomics-dedicated exchange traded funds, including the WisdomTree BioRevolution Fund (WDNA ). WDNA, which debuted earlier this year, tracks the WisdomTree BioRevolution Index (WTDNA).

WDNA offers investors a broad, efficient avenue for tapping into what’s an increasingly sprawling investment thesis. However, while genomics companies are working on various therapies and treatments, all it takes is one blockbuster to renew investors in the group. Improving Type 1 diabetes treatment could prove to be an example.

“Absent a set of reasonable possibilities for a large set of type 1 diabetes patients; scientists could turn to the possibilities of genetic research. In this case, the goal would be to somehow introduce insulin-producing cells into a patient, and to have those cells be genetically similar enough to that patient such that the patient’s immune system wouldn’t kill them,” notes Christopher Gannatti, WisdomTree global head of research.

The Benefit Of Its Weight

WDNA doesn’t allocate any more than 1.88% of its weight to any of its 111 holdings. That might sound like a detriment, but it’s a benefit because genetics research efforts can take years to bear fruit and, in the worst case, go awry, punishing equity prices in the process.

As just one example, one mentioned by Gannatti, Vertex Pharmaceuticals (NASDAQ: VRTX) is researching genetic implications in Type 1 diabetes, and “while initial results of the clinical trial appear to show some promise, it is important to note that there must be further study and testing to indicate if this approach is truly safe and effective.”

Looked at differently, it’s tempting to stock pick among genomics stocks because all of these companies are working on something that could improve quality of life. However, not all are successful, and investors’ chances of picking a dud in this space are as good if not better than choosing the next big thing in the biotechnology space. WDNA dramatically eases that burden while still offering investors significant upside potential.

“We believe WDNA uniquely positioned to provide exposure to companies that are reading, understanding, writing, and editing DNA for applications within the health care vertical and across interdisciplinary fields like agriculture, food, materials, chemicals, and energy production,” concludes Gannatti.

For more news, information, and strategy, visit the Model Portfolio Channel.


Content continues below advertisement

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X